188 related articles for article (PubMed ID: 14663321)
1. Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.
Nguyen JD; Carrasquillo JA; Little RF; Ryan QC; Wilson W; Chen CC
Clin Nucl Med; 2003 Dec; 28(12):979-80. PubMed ID: 14663321
[No Abstract] [Full Text] [Related]
2. Images in cardiovascular medicine. Metabolic imaging identifies non-Hodgkin's lymphoma infiltrating heart.
Römer W; Garbrecht M; Fuchs C; Schwaiger M
Circulation; 1998 Jun; 97(25):2577-8. PubMed ID: 9657480
[No Abstract] [Full Text] [Related]
3. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
4. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
[TBL] [Abstract][Full Text] [Related]
5. A case of malignant melanoma with cardiac and gallbladder metastases detected by FDG PET-CT.
Ozülker T; Ozülker F; Cicin I; Ozpaçac T
Clin Nucl Med; 2009 Dec; 34(12):948-9. PubMed ID: 20139846
[No Abstract] [Full Text] [Related]
6. FDG PET in the management of lymphoma: a clinical perspective.
Hoskin PJ
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):449-51. PubMed ID: 11914880
[No Abstract] [Full Text] [Related]
7. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
8. [18F-FDG whole-body positron-emission tomography (PET) in patients with unknown primary tumors].
Matheja P; Schober O
Strahlenther Onkol; 2000 Mar; 176(3):151-2. PubMed ID: 10742838
[No Abstract] [Full Text] [Related]
9. FDG positron emission tomography in lymphoma.
Tecnologica MAP Suppl; 2000 Jan; ():9-10. PubMed ID: 10848116
[No Abstract] [Full Text] [Related]
10. Fluorodeoxyglucose positron emission tomography excludes pericardial metastasis by recurrent lung cancer.
Ghesani NV; Sun X; Zhuang H; Sam JW; Alavi A
Clin Nucl Med; 2003 Aug; 28(8):666-7. PubMed ID: 12897654
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H
Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography imaging in melanoma and lymphoma.
Abella-Columna E; Valk PE
Semin Roentgenol; 2002 Apr; 37(2):129-39. PubMed ID: 12134366
[No Abstract] [Full Text] [Related]
14. Early restaging positron emission tomography with 18F-fluorodeoxyglucose in aggressive non-Hodgkin's lymphomas: is it too easy to be true?
Balzarotti M; Magagnoli M; Santoro A
Ann Oncol; 2003 Jul; 14(7):1155-6. PubMed ID: 12853364
[No Abstract] [Full Text] [Related]
15. Incidental detection of primary breast carcinoma with a modified coincident camera in a patient with non-Hodgkin's lymphoma and melanoma.
Pohland ML; Joyce JM; Myers DT; Petursson SR
Clin Nucl Med; 2002 Nov; 27(11):825-6. PubMed ID: 12394143
[No Abstract] [Full Text] [Related]
16. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.
Mijnhout GS; Pijpers R; Hoekstra OS; Teule GJ; Borgstein PJ; Meijer S
Cancer; 1999 Mar; 85(5):1199-201. PubMed ID: 10091807
[No Abstract] [Full Text] [Related]
17. Angiolipoma detected by F-18 FDG positron emission tomography.
Hsu CH; Yang CM; Cheng CJ
Clin Nucl Med; 2003 Jul; 28(7):604-5. PubMed ID: 12819423
[No Abstract] [Full Text] [Related]
18. Pelvic anatomic localization using ureteral activity on FDG positron emission tomography.
Lin EC; Siegal J
Clin Nucl Med; 2003 Oct; 28(10):836-7. PubMed ID: 14508276
[No Abstract] [Full Text] [Related]
19. Malignant melanoma staging using whole-body positron emission tomography.
Paquet P; Hustinx R; Rigo P; Piérard GE
Melanoma Res; 1998 Feb; 8(1):59-62. PubMed ID: 9508378
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care.
Kaplan LD
Am J Med; 2002 Mar; 112(4):320-1. PubMed ID: 11893374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
